Novartis AG

US · NVS #44 by market cap Listed 1970 Quant Rating D 49

159.99 -3.10 -1.90%

Live - 104 symbols - heartbeat 589s ago · 2026-09-04 20:02

Pre-market 159.89 -1.96%

After-hours 152.50 -4.68%

Overnight 161.48 -0.99%

Market cap: 304.10B
P/E (TTM): 24.17
P/B: 7.32
EPS: 7.15
Div yield: 2.96%
52W pos: 88%

About Novartis AG

Novartis is a Swiss pharmaceutical holding company whose portfolio centers on oncology, immunology, neuroscience and cardiovascular medicines, alongside a base of established older brands. It was formed by the 1996 merger of Ciba-Geigy and Sandoz and is headquartered in Basel, Switzerland.

Founded: 1996
CEO: Dr. Vasant Narasimhan
Employees: 75,267
Headquarters: Basel, Basel-Stadt (Basle Town), Switzerland
Fiscal year end: 12-31
Website: novartis.com

View SEC filings on EDGAR ›

Company profile

Exchange: US
Symbol: NVS
Market-cap rank: #44
Listing date: 1970-01-01
Market cap: 304.10B
Float cap: 297.00B
Shares out: 1.90B
Float shares: 1.86B

Sectors & themes

Drug Manufacturers - General CAR-T Therapy Cancer Research Fractional Shares JP

Browse all sectors & themes

Quote time 2026-09-04 20:02:17

For reference only, not investment advice.